REITs and healthcare are essential sectors, now out of favor as higher rates and tariff and regulatory fears weigh. Learn why ...

Goldman Sachs Nasdaq-100 Premium Income ETF stands out for its stability, tax benefits, and growth. Read why I recently added ...

Explore Q3 market performance, fund underperformance, and the transformative power of AI. Uncover our strategy for long-term ...

Emerging markets are undervalued, showing strong Q3 performance of 11.26%. Discover the promising outlook and key strategies ...

Calamos Convertible Opportunities and Income Fund navigated Q3 2025 with a 9.77% NAV return amid Fed rate cuts and strong ...

Cardinal Infrastructure's revenue growth is robust, driven by organic expansion and acquisitions. Read more on CDNL stock ...

Discover how a weakening labor market impacted the SLNZ ETF's 1.28% Q3 2025 gain. Click here to learn about our strategy for ...

S&P 500 EPS growth. Even with Broadcom and Oracle’s earnings reports last week, the expected “technology sector” growth rates ...

CytomX has confirmed a Q1'26 readout for additional data from its trial of CX-2051 in colorectal cancer. Read why CTMX stock ...

The recent sharp pullback in Cohen & Steers Infrastructure Fund creates a setup investors rarely see. Read why UTF CEF is ...

CONMED shares are nearing decade lows despite credible progress with supply issues. Click here to read more about CNMD stock.

Explore Greenlight Capital’s 2025 portfolio moves, new stock picks, and conviction buys. See performance insights vs. the S&P ...